The risk or severity of adverse effects can be increased when oxybutynin is combined with Tapentadol.


The risk or severity of adverse effects can be increased when nifedipine is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when linezolid is combined with clozapine.


The risk or severity of adverse effects can be increased when acebutolol is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when nylidrin is combined with PSEUDOEPHEDRINE.


The risk or severity of adverse effects can be increased when butabarbital is combined with enflurane.


The risk or severity of adverse effects can be increased when Teriflunomide is combined with flumethasone.


The risk or severity of adverse effects can be increased when Pramocaine is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when temazepam is combined with meclizine.


The risk or severity of adverse effects can be increased when nicergoline is combined with cabergoline.


The risk or severity of adverse effects can be increased when PERINDOPRIL is combined with Aceclofenac.


The risk or severity of adverse effects can be increased when temazepam is combined with risperidone.


The risk or severity of adverse effects can be increased when suprofen is combined with ketoprofen.


The risk or severity of adverse effects can be increased when bupivacaine is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when VORTIOXETINE is combined with Ramelteon.


The risk or severity of adverse effects can be increased when VORTIOXETINE is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when loxapine is combined with cetirizine.


The risk or severity of adverse effects can be increased when venlafaxine is combined with amisulpride.


The risk or severity of adverse effects can be increased when etodolac is combined with Loxoprofen.


The risk or severity of adverse effects can be increased when lisinopril is combined with ZILEUTON.


The risk or severity of adverse effects can be increased when indomethacin is combined with ketoprofen.


The risk or severity of adverse effects can be increased when etodolac is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when etodolac is combined with Droxicam.


The risk or severity of adverse effects can be increased when etodolac is combined with CLONIXIN.


The risk or severity of adverse effects can be increased when THYMOL is combined with Amrinone.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when Oxetacaine is combined with ethosuximide.


The risk or severity of adverse effects can be increased when quazepam is combined with propoxyphene.


The risk or severity of adverse effects can be increased when quazepam is combined with dyclonine.


The risk or severity of adverse effects can be increased when tolmetin is combined with medrysone.


The risk or severity of adverse effects can be increased when Escitalopram is combined with amisulpride.


The risk or severity of adverse effects can be increased when bromazepam is combined with tetracaine.


The risk or severity of adverse effects can be increased when isoproterenol is combined with DOXOFYLLINE.


The risk or severity of adverse effects can be increased when pentobarbital is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with Olopatadine.


The risk or severity of adverse effects can be increased when pentobarbital is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when LEVOBUNOLOL is combined with Nebivolol.


The risk or severity of adverse effects can be increased when clopidogrel is combined with diflunisal.


The risk or severity of adverse effects can be increased when methadone is combined with D-mannitol.


The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with etodolac.


The risk or severity of adverse effects can be increased when oxprenolol is combined with loratadine.


The risk or severity of adverse effects can be increased when oxprenolol is combined with imipramine.


The risk or severity of adverse effects can be increased when Normethadone is combined with Retigabine.


The risk or severity of adverse effects can be increased when ZILEUTON is combined with Mometasone.


The risk or severity of adverse effects can be increased when haloperidol is combined with Normethadone.


The risk or severity of adverse effects can be increased when fosinopril is combined with BALSALAZIDE.


The risk or severity of adverse effects can be increased when lorazepam is combined with Tramadol.


The risk or severity of adverse effects can be increased when Cilastatin is combined with meperidine.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when Droxicam is combined with Dehydroepiandrosterone.


The risk or severity of adverse effects can be increased when pimozide is combined with METAXALONE.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with cetirizine.


The risk or severity of adverse effects can be increased when venlafaxine is combined with tiapride.


The risk or severity of adverse effects can be increased when Fencamfamin is combined with levodopa.


The risk or severity of adverse effects can be increased when etizolam is combined with maprotiline.


The risk or severity of adverse effects can be increased when codeine is combined with trimipramine.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with DIHYDROCODEINE.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with altretamine.


The risk or severity of adverse effects can be increased when clemastine is combined with primidone.


The risk or severity of adverse effects can be increased when codeine is combined with procaine.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with bromazepam.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with Pefloxacin.


The risk or severity of adverse effects can be increased when methoxyflurane is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when VORTIOXETINE is combined with Tolcapone.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with Lenalidomide.


The risk or severity of adverse effects can be increased when VORTIOXETINE is combined with amitriptyline.


The risk or severity of adverse effects can be increased when VORTIOXETINE is combined with dihydroergotamine.


The risk or severity of adverse effects can be increased when risperidone is combined with Butethal.


The risk or severity of adverse effects can be increased when Eprosartan is combined with indomethacin.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with sulfinpyrazone.


The risk or severity of adverse effects can be increased when bromocriptine is combined with resveratrol.


The risk or severity of adverse effects can be increased when Calcium citrate is combined with Calcium acetate.


The risk or severity of adverse effects can be increased when BUPRANOLOL is combined with Carbamylcholine.


The risk or severity of adverse effects can be increased when Tolcapone is combined with CARTEOLOL.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with LEVOFLOXACIN.


The risk or severity of adverse effects can be increased when Tolcapone is combined with metolazone.


The risk or severity of adverse effects can be increased when Olopatadine is combined with sulfasalazine.


The risk or severity of adverse effects can be increased when amphotericin b is combined with eperisone.


The risk or severity of adverse effects can be increased when CARTEOLOL is combined with Telmisartan.


The risk or severity of adverse effects can be increased when amobarbital is combined with etizolam.


The risk or severity of adverse effects can be increased when flurbiprofen is combined with dexamethasone.


The risk or severity of adverse effects can be increased when topiramate is combined with methocarbamol.


The risk or severity of adverse effects can be increased when PERINDOPRIL is combined with SERATRODAST.


The risk or severity of adverse effects can be increased when CARTEOLOL is combined with apraclonidine.


The risk or severity of adverse effects can be increased when topiramate is combined with triprolidine.


The risk or severity of adverse effects can be increased when chlormezanone is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when Rufinamide is combined with gabapentin.


The risk or severity of adverse effects can be increased when aspirin is combined with Magnesium salicylate.


The risk or severity of adverse effects can be increased when biperiden is combined with buprenorphine.


The risk or severity of adverse effects can be increased when mesalamine is combined with Tixocortol.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with isocarboxazid.


The risk or severity of adverse effects can be increased when triazolam is combined with Levobupivacaine.


The risk or severity of adverse effects can be increased when Apremilast is combined with fenbufen.


The risk or severity of adverse effects can be increased when edrophonium is combined with Varenicline.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with procarbazine.


The risk or severity of adverse effects can be increased when Telmisartan is combined with Olsalazine.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with Topiroxostat.


The risk or severity of adverse effects can be increased when mepivacaine is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when Masoprocol is combined with CLOCORTOLONE.


The risk or severity of adverse effects can be increased when Telaprevir is combined with amiodarone.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with Pramocaine.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when Nepafenac is combined with nimesulide.


The risk or severity of adverse effects can be increased when trandolapril is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when hydroflumethiazide is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when nylidrin is combined with DOXOFYLLINE.


The risk or severity of adverse effects can be increased when Nepafenac is combined with epirizole.


The risk or severity of adverse effects can be increased when METYROSINE is combined with Dothiepin.


The risk or severity of adverse effects can be increased when CARTEOLOL is combined with methyldopa.


The risk or severity of adverse effects can be increased when Vecuronium is combined with SUFENTANIL.


The risk or severity of adverse effects can be increased when TETRABENAZINE is combined with Paliperidone.


The risk or severity of adverse effects can be increased when oxiconazole is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when buspirone is combined with quetiapine.


The risk or severity of adverse effects can be increased when buspirone is combined with ketamine.


The risk or severity of adverse effects can be increased when salicylic acid is combined with flurandrenolide.


The risk or severity of adverse effects can be increased when flurbiprofen is combined with desoximetasone.


The risk or severity of adverse effects can be increased when Enalaprilat is combined with thioridazine.


The risk or severity of adverse effects can be increased when Fluspirilene is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when fluvoxamine is combined with meclizine.


The risk or severity of adverse effects can be increased when tretinoin is combined with Eprosartan.


The risk or severity of adverse effects can be increased when diflunisal is combined with betamethasone.


The risk or severity of adverse effects can be increased when methysergide is combined with tamoxifen.


The risk or severity of adverse effects can be increased when epoprostenol is combined with spironolactone.


The risk or severity of adverse effects can be increased when nimesulide is combined with Apixaban.


The risk or severity of adverse effects can be increased when antipyrine is combined with CLONIXIN.


The risk or severity of adverse effects can be increased when Enalaprilat is combined with nimesulide.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when rescinnamine is combined with carprofen.


The risk or severity of adverse effects can be increased when nimodipine is combined with MAGNESIUM OXIDE.


The risk or severity of adverse effects can be increased when PIRFENIDONE is combined with Cis-mdp.


The risk or severity of adverse effects can be increased when Bexarotene is combined with clozapine.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with chlormezanone.


The risk or severity of adverse effects can be increased when zopiclone is combined with mesoridazine.


The risk or severity of adverse effects can be increased when propoxyphene is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with thioridazine.


The risk or severity of adverse effects can be increased when oxycodone is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when rapamycin is combined with Risedronic acid.


The risk or severity of adverse effects can be increased when antipyrine is combined with Loxoprofen.


The risk or severity of adverse effects can be increased when venlafaxine is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when quetiapine is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when lorazepam is combined with Ropivacaine.


The risk or severity of adverse effects can be increased when venlafaxine is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when biperiden is combined with oxyphenonium.


The risk or severity of adverse effects can be increased when fexofenadine is combined with clomipramine.


The risk or severity of adverse effects can be increased when hydrochlorothiazide is combined with quetiapine.


The risk or severity of adverse effects can be increased when midazolam is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with efavirenz.


The risk or severity of adverse effects can be increased when nabumetone is combined with methylprednisolone.


The risk or severity of adverse effects can be increased when reserpine is combined with Flibanserin.


The risk or severity of adverse effects can be increased when Masoprocol is combined with Fluprednidene.


The risk or severity of adverse effects can be increased when Tiotropium is combined with morphine.


The risk or severity of adverse effects can be increased when hydromorphone is combined with nitrous oxide.


The risk or severity of adverse effects can be increased when bromocriptine is combined with cyclophosphamide.


The risk or severity of adverse effects can be increased when bromocriptine is combined with ciprofloxacin.


The risk or severity of adverse effects can be increased when antipyrine is combined with Droxicam.


The risk or severity of adverse effects can be increased when resveratrol is combined with Clobetasone.


The risk or severity of adverse effects can be increased when Dapagliflozin is combined with Canagliflozin.


The risk or severity of adverse effects can be increased when barnidipine is combined with MAGNESIUM SULFATE.


The risk or severity of adverse effects can be increased when fenoprofen is combined with salicylamide.


The risk or severity of adverse effects can be increased when barnidipine is combined with mecamylamine.


The risk or severity of adverse effects can be increased when Apremilast is combined with triamcinolone.


The risk or severity of adverse effects can be increased when oxaprozin is combined with difluprednate.


The risk or severity of adverse effects can be increased when morphine is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with nitrous oxide.


The risk or severity of adverse effects can be increased when oxaprozin is combined with halcinonide.


The risk or severity of adverse effects can be increased when diazepam is combined with tiapride.


The risk or severity of adverse effects can be increased when Rotigotine is combined with triamterene.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with amisulpride.


The risk or severity of adverse effects can be increased when methysergide is combined with sertraline.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when Lofexidine is combined with nitric oxide.


The risk or severity of adverse effects can be increased when methysergide is combined with pimozide.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with Vilanterol.


The risk or severity of adverse effects can be increased when sulindac is combined with mycophenolic acid.


The risk or severity of adverse effects can be increased when pirenzepine is combined with Pentolinium.


The risk or severity of adverse effects can be increased when salicylic acid is combined with FLUOCINOLONE ACETONIDE.


The risk or severity of adverse effects can be increased when amoxapine is combined with naratriptan.


The risk or severity of adverse effects can be increased when salicylic acid is combined with Halobetasol.


The risk or severity of adverse effects can be increased when isoflurane is combined with Riociguat.


The risk or severity of adverse effects can be increased when butalbital is combined with loratadine.


The risk or severity of adverse effects can be increased when MELPERONE is combined with promethazine.


The risk or severity of adverse effects can be increased when methoxyflurane is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when diazepam is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when Rotigotine is combined with mecamylamine.


The risk or severity of adverse effects can be increased when DIMENHYDRINATE is combined with Milnacipran.


The risk or severity of adverse effects can be increased when Treprostinil is combined with Salsalate.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with Flibanserin.


The risk or severity of adverse effects can be increased when cilnidipine is combined with phenoxybenzamine.


The risk or severity of adverse effects can be increased when aspirin is combined with Salsalate.


The risk or severity of adverse effects can be increased when DEXKETOPROFEN is combined with oxaprozin.


The risk or severity of adverse effects can be increased when labetalol is combined with D-mannitol.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with trimipramine.


The risk or severity of adverse effects can be increased when trazodone is combined with Articaine.


The risk or severity of adverse effects can be increased when mycophenolic acid is combined with Lumiracoxib.


The risk or severity of adverse effects can be increased when DEXKETOPROFEN is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when Conivaptan is combined with NITROUS ACID.


The risk or severity of adverse effects can be increased when TASOSARTAN is combined with carprofen.


The risk or severity of adverse effects can be increased when Milnacipran is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when Melatonin is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when enflurane is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when ETHACRYNIC ACID is combined with Nebivolol.


The risk or severity of adverse effects can be increased when enflurane is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when mepivacaine is combined with Iloperidone.


The risk or severity of adverse effects can be increased when Mometasone is combined with NEOSTIGMINE.


The risk or severity of adverse effects can be increased when amphotericin b is combined with triamterene.


The risk or severity of adverse effects can be increased when fluvoxamine is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when LISURIDE is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when metoclopramide is combined with clomipramine.


The risk or severity of adverse effects can be increased when enflurane is combined with meclizine.


The risk or severity of adverse effects can be increased when resveratrol is combined with homoharringtonine.


The risk or severity of adverse effects can be increased when DESONIDE is combined with enoxacin.


The risk or severity of adverse effects can be increased when desoximetasone is combined with memantine.


The risk or severity of adverse effects can be increased when ethotoin is combined with duloxetine.


The risk or severity of adverse effects can be increased when enflurane is combined with clomipramine.


The risk or severity of adverse effects can be increased when RIMEXOLONE is combined with Deferasirox.


The risk or severity of adverse effects can be increased when ethotoin is combined with fluoxetine.


The risk or severity of adverse effects can be increased when nitroglycerin is combined with quetiapine.


The risk or severity of adverse effects can be increased when MEPHENTERMINE is combined with hydroxyamphetamine.


The risk or severity of adverse effects can be increased when morphine is combined with methyclothiazide.


The risk or severity of adverse effects can be increased when mycophenolate mofetil is combined with desoximetasone.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with atenolol.


The risk or severity of adverse effects can be increased when imipramine is combined with Almotriptan.


The risk or severity of adverse effects can be increased when Vorapaxar is combined with Bivalirudin.


The risk or severity of adverse effects can be increased when nisoldipine is combined with nitroglycerin.


The risk or severity of adverse effects can be increased when zotepine is combined with felbamate.


The risk or severity of adverse effects can be increased when Posaconazole is combined with toremifene.


The risk or severity of adverse effects can be increased when tiapride is combined with meclizine.


The risk or severity of adverse effects can be increased when Tapentadol is combined with Alvimopan.


The risk or severity of adverse effects can be increased when dihydroergotamine is combined with Linagliptin.


The risk or severity of adverse effects can be increased when enalapril is combined with Pimecrolimus.


The risk or severity of adverse effects can be increased when sevoflurane is combined with chlorothiazide.


The risk or severity of adverse effects can be increased when orphenadrine is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when sevoflurane is combined with ISOSORBIDE DINITRATE.


The risk or severity of adverse effects can be increased when bromocriptine is combined with Lofexidine.


The risk or severity of adverse effects can be increased when pergolide is combined with Elbasvir.


The risk or severity of adverse effects can be increased when atenolol is combined with nicardipine.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when lisinopril is combined with Pregabalin.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with butamben.


The risk or severity of adverse effects can be increased when Ibrutinib is combined with aspirin.


The risk or severity of adverse effects can be increased when Ibrutinib is combined with PHENPROCOUMON.


The risk or severity of adverse effects can be increased when HYDROCODONE is combined with Drospirenone.


The risk or severity of adverse effects can be increased when nalbuphine is combined with thiothixene.


The risk or severity of adverse effects can be increased when TROLEANDOMYCIN is combined with atorvastatin.


The risk or severity of adverse effects can be increased when Clofarabine is combined with carvedilol.


The risk or severity of adverse effects can be increased when nalbuphine is combined with Zuclopenthixol.


The risk or severity of adverse effects can be increased when betaxolol is combined with Varenicline.


The risk or severity of adverse effects can be increased when meprobamate is combined with prochlorperazine.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with diltiazem.


The risk or severity of adverse effects can be increased when Spirapril is combined with indomethacin.


The risk or severity of adverse effects can be increased when difluprednate is combined with mefloquine.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with thiotepa.


The risk or severity of adverse effects can be increased when clozapine is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when FLUOCINOLONE ACETONIDE is combined with fleroxacin.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Estrone sulfate.


The risk or severity of adverse effects can be increased when Etidocaine is combined with baclofen.


The risk or severity of adverse effects can be increased when clozapine is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when Etomidate is combined with glutethimide.


The risk or severity of adverse effects can be increased when quazepam is combined with clozapine.


The risk or severity of adverse effects can be increased when metoclopramide is combined with ondansetron.


The risk or severity of adverse effects can be increased when Eletriptan is combined with Escitalopram.


The risk or severity of adverse effects can be increased when Articaine is combined with Ramelteon.


The risk or severity of adverse effects can be increased when amphotericin b is combined with selegiline.


The risk or severity of adverse effects can be increased when Artemether is combined with Pinaverium.


The risk or severity of adverse effects can be increased when Articaine is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when alclofenac is combined with hydrocortisone.


The risk or severity of adverse effects can be increased when MOLINDONE is combined with clomipramine.


The risk or severity of adverse effects can be increased when ETOFENAMATE is combined with flumethasone.


The risk or severity of adverse effects can be increased when Tolcapone is combined with Milnacipran.


The risk or severity of adverse effects can be increased when Tramadol is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when Fesoterodine is combined with Propiverine.


The risk or severity of adverse effects can be increased when PERINDOPRIL is combined with BENZYDAMINE.


The risk or severity of adverse effects can be increased when reserpine is combined with primidone.


The risk or severity of adverse effects can be increased when carisoprodol is combined with tizanidine.


The risk or severity of adverse effects can be increased when Propacetamol is combined with Zoledronic acid.


The risk or severity of adverse effects can be increased when procaine is combined with clidinium.


The risk or severity of adverse effects can be increased when papaverine is combined with quetiapine.


The risk or severity of adverse effects can be increased when fluvoxamine is combined with HEROIN.


The risk or severity of adverse effects can be increased when ibuprofen is combined with haloperidol.


The risk or severity of adverse effects can be increased when Propacetamol is combined with BECLOMETHASONE DIPROPIONATE.


The risk or severity of adverse effects can be increased when Talniflumate is combined with sulfasalazine.


The risk or severity of adverse effects can be increased when butorphanol is combined with Levobupivacaine.


The risk or severity of adverse effects can be increased when Bortezomib is combined with ESMOLOL.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with triamterene.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with efavirenz.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with FLUPHENAZINE.


The risk or severity of adverse effects can be increased when methylergonovine is combined with haloperidol.


The risk or severity of adverse effects can be increased when Flupentixol is combined with triflupromazine.


The risk or severity of adverse effects can be increased when ETOFENAMATE is combined with FLUOCINOLONE ACETONIDE.


The risk or severity of adverse effects can be increased when Paliperidone is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when scopolamine is combined with PIPECURONIUM.


The risk or severity of adverse effects can be increased when ETOFENAMATE is combined with Halobetasol.


The risk or severity of adverse effects can be increased when methocarbamol is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when scopolamine is combined with Vecuronium.


The risk or severity of adverse effects can be increased when ADAPALENE is combined with niflumic acid.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with Desloratadine.


The risk or severity of adverse effects can be increased when thalidomide is combined with propranolol.


The risk or severity of adverse effects can be increased when tacrolimus is combined with triamcinolone.


The risk or severity of adverse effects can be increased when Nitroprusside is combined with acebutolol.


The risk or severity of adverse effects can be increased when Hexobarbital is combined with Difenoxin.


The risk or severity of adverse effects can be increased when fluocinonide is combined with malathion.


The risk or severity of adverse effects can be increased when pentostatin is combined with clozapine.


The risk or severity of adverse effects can be increased when chloroquine is combined with mycophenolate mofetil.


The risk or severity of adverse effects can be increased when fluocinonide is combined with nalidixic acid.


The risk or severity of adverse effects can be increased when bepridil is combined with atenolol.


The risk or severity of adverse effects can be increased when nicergoline is combined with histamine.


The risk or severity of adverse effects can be increased when benzoic acid is combined with Pinaverium.


The risk or severity of adverse effects can be increased when propofol is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when pargyline is combined with ARBUTAMINE.


The risk or severity of adverse effects can be increased when fluoxetine is combined with Pipamperone.


The risk or severity of adverse effects can be increased when Salsalate is combined with RIMEXOLONE.


The risk or severity of adverse effects can be increased when propofol is combined with Ramelteon.


The risk or severity of adverse effects can be increased when dibucaine is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when chlormezanone is combined with lithium ion.


The risk or severity of adverse effects can be increased when chlormezanone is combined with Hexobarbital.


The risk or severity of adverse effects can be increased when Phenelzine is combined with quetiapine.


The risk or severity of adverse effects can be increased when chlormezanone is combined with Butethal.


The risk or severity of adverse effects can be increased when docetaxel is combined with irinotecan.


The risk or severity of adverse effects can be increased when D-mannitol is combined with bumetanide.


The risk or severity of adverse effects can be increased when ILOPROST is combined with thalidomide.


The risk or severity of adverse effects can be increased when Bortezomib is combined with oxprenolol.


The risk or severity of adverse effects can be increased when amoxapine is combined with efavirenz.


The risk or severity of adverse effects can be increased when nortriptyline is combined with clidinium.


The risk or severity of adverse effects can be increased when tetracaine is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when sevoflurane is combined with Apixaban.


The risk or severity of adverse effects can be increased when zonisamide is combined with levodopa.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with Etidocaine.


The risk or severity of adverse effects can be increased when ESMOLOL is combined with losartan.


The risk or severity of adverse effects can be increased when flurazepam is combined with Flibanserin.


The risk or severity of adverse effects can be increased when calcium lactate is combined with ceftriaxone.


The risk or severity of adverse effects can be increased when nadolol is combined with hydralazine.


The risk or severity of adverse effects can be increased when HEROIN is combined with topiramate.


The risk or severity of adverse effects can be increased when tolterodine is combined with butorphanol.


The risk or severity of adverse effects can be increased when nadolol is combined with Varenicline.


The risk or severity of adverse effects can be increased when clorazepate is combined with pimozide.


The risk or severity of adverse effects can be increased when zaltoprofen is combined with Dehydroepiandrosterone.


The risk or severity of adverse effects can be increased when Bortezomib is combined with terazosin.


The risk or severity of adverse effects can be increased when buspirone is combined with clorazepate.


The risk or severity of adverse effects can be increased when Agomelatine is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when efavirenz is combined with METAXALONE.


The risk or severity of adverse effects can be increased when zopiclone is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when butorphanol is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when ketorolac is combined with formestane.


The risk or severity of adverse effects can be increased when ketorolac is combined with Fluticasone furoate.


The risk or severity of adverse effects can be increased when clonidine is combined with captopril.


The risk or severity of adverse effects can be increased when Atazanavir is combined with toremifene.


The risk or severity of adverse effects can be increased when protriptyline is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when Prasugrel is combined with TROLAMINE SALICYLATE.


The risk or severity of adverse effects can be increased when imipramine is combined with carvedilol.


The risk or severity of adverse effects can be increased when Atazanavir is combined with cyclophosphamide.


The risk or severity of adverse effects can be increased when azelastine is combined with Escitalopram.


The risk or severity of adverse effects can be increased when Olmesartan is combined with enalapril.


The risk or severity of adverse effects can be increased when Olmesartan is combined with diclofenac.


The risk or severity of adverse effects can be increased when triflupromazine is combined with cetirizine.


The risk or severity of adverse effects can be increased when Desloratadine is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when EFINACONAZOLE is combined with Pinaverium.


The risk or severity of adverse effects can be increased when prazepam is combined with Agomelatine.


The risk or severity of adverse effects can be increased when chlorprothixene is combined with Flibanserin.


The risk or severity of adverse effects can be increased when isoflurane is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when isradipine is combined with nicardipine.


The risk or severity of adverse effects can be increased when Linagliptin is combined with lisinopril.


The risk or severity of adverse effects can be increased when BALSALAZIDE is combined with RIMEXOLONE.


The risk or severity of adverse effects can be increased when fenoprofen is combined with PIRFENIDONE.


The risk or severity of adverse effects can be increased when Bortezomib is combined with prazosin.


The risk or severity of adverse effects can be increased when Eprosartan is combined with mycophenolic acid.


The risk or severity of adverse effects can be increased when prazosin is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when Triflusal is combined with DEOXYCHOLIC ACID.


The risk or severity of adverse effects can be increased when Lormetazepam is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Fospropofol.


The risk or severity of adverse effects can be increased when oxyphenbutazone is combined with flurandrenolide.


The risk or severity of adverse effects can be increased when methyclothiazide is combined with irbesartan.


The risk or severity of adverse effects can be increased when promazine is combined with Difenoxin.


The risk or severity of adverse effects can be increased when dibucaine is combined with butalbital.


The risk or severity of adverse effects can be increased when ondansetron is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Lenalidomide.


The risk or severity of adverse effects can be increased when resveratrol is combined with Ibandronic Acid.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with estazolam.


The risk or severity of adverse effects can be increased when Telmisartan is combined with Lornoxicam.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with altretamine.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with dantrolene.


The risk or severity of adverse effects can be increased when Telmisartan is combined with papaverine.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with triprolidine.


The risk or severity of adverse effects can be increased when TROLAMINE SALICYLATE is combined with flunisolide.


The risk or severity of adverse effects can be increased when Tavaborole is combined with diltiazem.


The risk or severity of adverse effects can be increased when trimetrexate is combined with Pregabalin.


The risk or severity of adverse effects can be increased when Glubionate calcium is combined with ceftriaxone.


The risk or severity of adverse effects can be increased when chloral hydrate is combined with butalbital.


The risk or severity of adverse effects can be increased when Rufinamide is combined with Levobupivacaine.


The risk or severity of adverse effects can be increased when lorazepam is combined with 4-Hydroxybutanoic acid.


The risk or severity of adverse effects can be increased when sulpiride is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when Arotinolol is combined with nimodipine.


The risk or severity of adverse effects can be increased when diazepam is combined with proparacaine.


The risk or severity of adverse effects can be increased when diazepam is combined with Halazepam.


The risk or severity of adverse effects can be increased when bromocriptine is combined with losartan.


The risk or severity of adverse effects can be increased when Fluticasone furoate is combined with fleroxacin.


The risk or severity of adverse effects can be increased when olanzapine is combined with Normethadone.


The risk or severity of adverse effects can be increased when bromocriptine is combined with tamoxifen.


The risk or severity of adverse effects can be increased when AZILSARTAN MEDOXOMIL is combined with Apremilast.


The risk or severity of adverse effects can be increased when thiopental is combined with halothane.


The risk or severity of adverse effects can be increased when ketoprofen is combined with ibuprofen.


The risk or severity of adverse effects can be increased when chlorzoxazone is combined with atorvastatin.


The risk or severity of adverse effects can be increased when Miltefosine is combined with diltiazem.


The risk or severity of adverse effects can be increased when zotepine is combined with clonidine.


The risk or severity of adverse effects can be increased when sulindac is combined with Apremilast.


The risk or severity of adverse effects can be increased when haloperidol is combined with thiopental.


The risk or severity of adverse effects can be increased when Masoprocol is combined with sulindac.


The risk or severity of adverse effects can be increased when butorphanol is combined with Etidocaine.


The risk or severity of adverse effects can be increased when dibucaine is combined with Milnacipran.


The risk or severity of adverse effects can be increased when secobarbital is combined with butorphanol.


The risk or severity of adverse effects can be increased when methysergide is combined with omeprazole.


The risk or severity of adverse effects can be increased when butalbital is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when methysergide is combined with olanzapine.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when zaltoprofen is combined with Propacetamol.


The risk or severity of adverse effects can be increased when methysergide is combined with methadone.


The risk or severity of adverse effects can be increased when salicylic acid is combined with BENZYDAMINE.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with mesoridazine.


The risk or severity of adverse effects can be increased when Lercanidipine is combined with atorvastatin.


The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Tenofovir disoproxil.


The risk or severity of adverse effects can be increased when Levomilnacipran is combined with Lurasidone.


The risk or severity of adverse effects can be increased when suprofen is combined with hydrocortisone.


The risk or severity of adverse effects can be increased when Sacubitril is combined with niflumic acid.


The risk or severity of adverse effects can be increased when CICLOPIROX is combined with xylometazoline.


The risk or severity of adverse effects can be increased when sevoflurane is combined with clidinium.


The risk or severity of adverse effects can be increased when fenoprofen is combined with Fluticasone furoate.


The risk or severity of adverse effects can be increased when AMILORIDE is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when fexofenadine is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when Conivaptan is combined with nitric oxide.


The risk or severity of adverse effects can be increased when Pipamperone is combined with Retigabine.


The risk or severity of adverse effects can be increased when Conivaptan is combined with BENDROFLUMETHIAZIDE.


The risk or severity of adverse effects can be increased when methylergonovine is combined with alprazolam.


The risk or severity of adverse effects can be increased when CYPROHEPTADINE is combined with felbamate.


The risk or severity of adverse effects can be increased when methylergonovine is combined with venlafaxine.


The risk or severity of adverse effects can be increased when methylergonovine is combined with nisoldipine.


The risk or severity of adverse effects can be increased when Fluticasone furoate is combined with ambenonium.


The risk or severity of adverse effects can be increased when isoflurane is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when nalbuphine is combined with Mersalyl.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with paroxetine.


The risk or severity of adverse effects can be increased when Ibrutinib is combined with EDOXABAN.


The risk or severity of adverse effects can be increased when METYROSINE is combined with sertraline.


The risk or severity of adverse effects can be increased when sulpiride is combined with dibucaine.


The risk or severity of adverse effects can be increased when morniflumate is combined with Loxoprofen.


The risk or severity of adverse effects can be increased when morniflumate is combined with Droxicam.


The risk or severity of adverse effects can be increased when morniflumate is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when phenobarbital is combined with topiramate.


The risk or severity of adverse effects can be increased when morniflumate is combined with CLONIXIN.


The risk or severity of adverse effects can be increased when butalbital is combined with Fosphenytoin.


The risk or severity of adverse effects can be increased when diflorasone is combined with LEVOFLOXACIN.


The risk or severity of adverse effects can be increased when indinavir is combined with Temsirolimus.


The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with flunarizine.


The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when Pipamperone is combined with TAMSULOSIN.


The risk or severity of adverse effects can be increased when diltiazem is combined with Metipranolol.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when clotrimazole is combined with nitrendipine.


The risk or severity of adverse effects can be increased when Pipamperone is combined with Eplerenone.


The risk or severity of adverse effects can be increased when PERINDOPRIL is combined with oxaprozin.


The risk or severity of adverse effects can be increased when spironolactone is combined with benazepril.


The risk or severity of adverse effects can be increased when flurbiprofen is combined with DEFLAZACORT.


The risk or severity of adverse effects can be increased when diflunisal is combined with Ticagrelor.


The risk or severity of adverse effects can be increased when halothane is combined with Agomelatine.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with thiopental.


The risk or severity of adverse effects can be increased when fenbufen is combined with Loxoprofen.


The risk or severity of adverse effects can be increased when fenbufen is combined with Droxicam.


The risk or severity of adverse effects can be increased when Difenoxin is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when fenbufen is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when Hexobarbital is combined with paroxetine.


The risk or severity of adverse effects can be increased when haloprogin is combined with barnidipine.


The risk or severity of adverse effects can be increased when Lurasidone is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when Lurasidone is combined with flunitrazepam.


The risk or severity of adverse effects can be increased when Arotinolol is combined with papaverine.


The risk or severity of adverse effects can be increased when methylphenidate is combined with mirtazapine.


The risk or severity of adverse effects can be increased when bromocriptine is combined with ifosfamide.


The risk or severity of adverse effects can be increased when meperidine is combined with 4-Hydroxybutanoic acid.


The risk or severity of adverse effects can be increased when fenofibrate is combined with Coenzyme Q10.


The risk or severity of adverse effects can be increased when MOLINDONE is combined with ethosuximide.


The risk or severity of adverse effects can be increased when bromocriptine is combined with DESFLURANE.


The risk or severity of adverse effects can be increased when temazepam is combined with butalbital.


The risk or severity of adverse effects can be increased when cilazapril is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when triazolam is combined with meclizine.


The risk or severity of adverse effects can be increased when bromocriptine is combined with hydralazine.


The risk or severity of adverse effects can be increased when oxymorphone is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with tizanidine.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with furosemide.


The risk or severity of adverse effects can be increased when procaine is combined with Oxybuprocaine.


The risk or severity of adverse effects can be increased when cilazapril is combined with floctafenine.


The risk or severity of adverse effects can be increased when ethosuximide is combined with meclizine.


The risk or severity of adverse effects can be increased when Tedizolid phosphate is combined with risperidone.


The risk or severity of adverse effects can be increased when SERATRODAST is combined with acemetacin.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when lorazepam is combined with proparacaine.


The risk or severity of adverse effects can be increased when ketamine is combined with methoxyflurane.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with QUINETHAZONE.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with polythiazide.


The risk or severity of adverse effects can be increased when Ibrutinib is combined with Bivalirudin.


The risk or severity of adverse effects can be increased when flurazepam is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when lorazepam is combined with Halazepam.


The risk or severity of adverse effects can be increased when codeine is combined with metolazone.


The risk or severity of adverse effects can be increased when isoflurane is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when codeine is combined with dibucaine.


The risk or severity of adverse effects can be increased when atenolol is combined with papaverine.


The risk or severity of adverse effects can be increased when PERHEXILINE is combined with Coenzyme Q10.


The risk or severity of adverse effects can be increased when lidocaine is combined with Difenoxin.


The risk or severity of adverse effects can be increased when amiodarone is combined with tolazoline.


The risk or severity of adverse effects can be increased when amiodarone is combined with PERINDOPRIL.


The risk or severity of adverse effects can be increased when Talniflumate is combined with fenbufen.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with LEVOSIMENDAN.


The risk or severity of adverse effects can be increased when diltiazem is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with tranylcypromine.


The risk or severity of adverse effects can be increased when Talniflumate is combined with ETOFENAMATE.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with phenoxybenzamine.


The risk or severity of adverse effects can be increased when fenbufen is combined with prednisone.


The risk or severity of adverse effects can be increased when methysergide is combined with metyrapone.


The risk or severity of adverse effects can be increased when fenbufen is combined with ALENDRONIC ACID.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with selegiline.


The risk or severity of adverse effects can be increased when midazolam is combined with dibucaine.


The risk or severity of adverse effects can be increased when lorazepam is combined with haloperidol.


The risk or severity of adverse effects can be increased when procaine is combined with nefazodone.


The risk or severity of adverse effects can be increased when phenmetrazine is combined with benzphetamine.


The risk or severity of adverse effects can be increased when terbutaline is combined with isoproterenol.


The risk or severity of adverse effects can be increased when phenmetrazine is combined with ritodrine.


The risk or severity of adverse effects can be increased when resveratrol is combined with acemetacin.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when procaine is combined with doxepin.


The risk or severity of adverse effects can be increased when Etomidate is combined with meclizine.


The risk or severity of adverse effects can be increased when diphenhydramine is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when venlafaxine is combined with trimipramine.


The risk or severity of adverse effects can be increased when glutethimide is combined with sertraline.


The risk or severity of adverse effects can be increased when diphenhydramine is combined with Pramocaine.


The risk or severity of adverse effects can be increased when ritodrine is combined with dopamine.


The risk or severity of adverse effects can be increased when topiramate is combined with Iloperidone.


The risk or severity of adverse effects can be increased when pramipexole is combined with tretinoin.


The risk or severity of adverse effects can be increased when desipramine is combined with procarbazine.


The risk or severity of adverse effects can be increased when hydromorphone is combined with meprobamate.


The risk or severity of adverse effects can be increased when mesoridazine is combined with CHLOROPROCAINE.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with D-mannitol.


The risk or severity of adverse effects can be increased when histamine is combined with atorvastatin.


The risk or severity of adverse effects can be increased when acemetacin is combined with formestane.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with PROCATEROL.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with scopolamine.


The risk or severity of adverse effects can be increased when chloroquine is combined with Lumiracoxib.


The risk or severity of adverse effects can be increased when Eletriptan is combined with FLUPHENAZINE.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when ketamine is combined with propoxyphene.


The risk or severity of adverse effects can be increased when Almotriptan is combined with Iloperidone.


The risk or severity of adverse effects can be increased when estazolam is combined with loratadine.


The risk or severity of adverse effects can be increased when nicergoline is combined with roxithromycin.


The risk or severity of adverse effects can be increased when zafirlukast is combined with atorvastatin.


The risk or severity of adverse effects can be increased when propofol is combined with trandolapril.


The risk or severity of adverse effects can be increased when FLUTICASONE PROPIONATE is combined with Olopatadine.


The risk or severity of adverse effects can be increased when Tedizolid phosphate is combined with ACETOPHENAZINE.


The risk or severity of adverse effects can be increased when Toloxatone is combined with metaproterenol.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with chlormezanone.


The risk or severity of adverse effects can be increased when isoflurane is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when TROLAMINE SALICYLATE is combined with methylprednisolone.


The risk or severity of adverse effects can be increased when oxymorphone is combined with pargyline.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with moclobemide.


The risk or severity of adverse effects can be increased when nalbuphine is combined with Agomelatine.


The risk or severity of adverse effects can be increased when bromocriptine is combined with sevoflurane.


The risk or severity of adverse effects can be increased when citalopram is combined with loxapine.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when amprenavir is combined with cyclophosphamide.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when chlorzoxazone is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when phenylpropanolamine is combined with phenmetrazine.


The risk or severity of adverse effects can be increased when sevoflurane is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when amitriptyline is combined with terbutaline.


The risk or severity of adverse effects can be increased when Atracurium besylate is combined with SUFENTANIL.


The risk or severity of adverse effects can be increased when penbutolol is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with enflurane.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with FLUPHENAZINE.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with efavirenz.


The risk or severity of adverse effects can be increased when captopril is combined with PIRFENIDONE.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with clorazepate.


The risk or severity of adverse effects can be increased when ketorolac is combined with mesalamine.


The risk or severity of adverse effects can be increased when maprotiline is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when ketorolac is combined with alclometasone.


The risk or severity of adverse effects can be increased when doxepin is combined with celiprolol.


The risk or severity of adverse effects can be increased when bromazepam is combined with Olopatadine.


The risk or severity of adverse effects can be increased when doxepin is combined with flunarizine.


The risk or severity of adverse effects can be increased when amoxapine is combined with levodopa.


The risk or severity of adverse effects can be increased when trihexyphenidyl is combined with TRIMETHAPHAN.


The risk or severity of adverse effects can be increased when gabapentin is combined with bromazepam.


The risk or severity of adverse effects can be increased when chloroquine is combined with Risedronic acid.


The risk or severity of adverse effects can be increased when tolfenamic acid is combined with Halobetasol.


The risk or severity of adverse effects can be increased when tolfenamic acid is combined with FLUOCINOLONE ACETONIDE.


The risk or severity of adverse effects can be increased when Fencamfamin is combined with butamben.


The risk or severity of adverse effects can be increased when flurazepam is combined with doxepin.


The risk or severity of adverse effects can be increased when codeine is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when fluvoxamine is combined with Pipamperone.


The risk or severity of adverse effects can be increased when diphenhydramine is combined with chlormezanone.


The risk or severity of adverse effects can be increased when Treprostinil is combined with sulfasalazine.


The risk or severity of adverse effects can be increased when Tramadol is combined with 4-Hydroxybutanoic acid.


The risk or severity of adverse effects can be increased when prazepam is combined with zotepine.


The risk or severity of adverse effects can be increased when meclofenamic acid is combined with betamethasone.


The risk or severity of adverse effects can be increased when PERINDOPRIL is combined with tenoxicam.


The risk or severity of adverse effects can be increased when Estrone sulfate is combined with fleroxacin.


The risk or severity of adverse effects can be increased when Salsalate is combined with amcinonide.


The risk or severity of adverse effects can be increased when PERINDOPRIL is combined with nabumetone.


The risk or severity of adverse effects can be increased when butamben is combined with Flibanserin.


The risk or severity of adverse effects can be increased when halothane is combined with METAXALONE.


The risk or severity of adverse effects can be increased when PERINDOPRIL is combined with ketorolac.


The risk or severity of adverse effects can be increased when Salsalate is combined with PAMIDRONIC ACID.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with Olopatadine.


The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when trihexyphenidyl is combined with biperiden.


The risk or severity of adverse effects can be increased when Phenelzine is combined with clozapine.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with triflupromazine.


The risk or severity of adverse effects can be increased when Etomidate is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when Desloratadine is combined with doxepin.


The risk or severity of adverse effects can be increased when Desloratadine is combined with nefazodone.


The risk or severity of adverse effects can be increased when pentazocine is combined with Tolvaptan.


The risk or severity of adverse effects can be increased when pentamidine is combined with Amrinone.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with fluoxetine.


The risk or severity of adverse effects can be increased when quetiapine is combined with mepivacaine.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with zonisamide.


The risk or severity of adverse effects can be increased when quetiapine is combined with Desloratadine.


The risk or severity of adverse effects can be increased when benzyl alcohol is combined with amoxapine.


The risk or severity of adverse effects can be increased when ethyl loflazepate is combined with Fosphenytoin.


The risk or severity of adverse effects can be increased when barnidipine is combined with pramipexole.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with tiagabine.


The risk or severity of adverse effects can be increased when ketamine is combined with Perospirone.


The risk or severity of adverse effects can be increased when nalbuphine is combined with methyclothiazide.


The risk or severity of adverse effects can be increased when Eplerenone is combined with apraclonidine.


The risk or severity of adverse effects can be increased when nilvadipine is combined with sevoflurane.


The risk or severity of adverse effects can be increased when bromazepam is combined with ethchlorvynol.


The risk or severity of adverse effects can be increased when Torasemide is combined with BISOPROLOL.


The risk or severity of adverse effects can be increased when bromazepam is combined with baclofen.


The risk or severity of adverse effects can be increased when ipratropium is combined with oxycodone.


The risk or severity of adverse effects can be increased when butabarbital is combined with levorphanol.


The risk or severity of adverse effects can be increased when BENDROFLUMETHIAZIDE is combined with losartan.


The risk or severity of adverse effects can be increased when butabarbital is combined with perphenazine.


The risk or severity of adverse effects can be increased when mycophenolate mofetil is combined with zaltoprofen.


The risk or severity of adverse effects can be increased when mycophenolate mofetil is combined with Aceclofenac.


The risk or severity of adverse effects can be increased when mycophenolate mofetil is combined with SERATRODAST.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with ondansetron.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with tiagabine.


The risk or severity of adverse effects can be increased when tolmetin is combined with equilin.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when timolol is combined with BISOPROLOL.


The risk or severity of adverse effects can be increased when mesoridazine is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when methyclothiazide is combined with cilazapril.


The risk or severity of adverse effects can be increased when meclizine is combined with citalopram.


The risk or severity of adverse effects can be increased when Loxoprofen is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when diclofenac is combined with indomethacin.


The risk or severity of adverse effects can be increased when temazepam is combined with tizanidine.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with flunarizine.


The risk or severity of adverse effects can be increased when ZILEUTON is combined with NAPROXEN.


The risk or severity of adverse effects can be increased when Eplerenone is combined with methyldopa.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with lithium ion.


The risk or severity of adverse effects can be increased when Artemether is combined with eperisone.


The risk or severity of adverse effects can be increased when trihexyphenidyl is combined with methscopolamine.


The risk or severity of adverse effects can be increased when oxycodone is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when meperidine is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when NITROUS ACID is combined with ramipril.


The risk or severity of adverse effects can be increased when meperidine is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when thiamylal is combined with vigabatrin.


The risk or severity of adverse effects can be increased when clarithromycin is combined with Abemaciclib.


The risk or severity of adverse effects can be increased when difluprednate is combined with decamethonium.


The risk or severity of adverse effects can be increased when betaxolol is combined with D-mannitol.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with zotepine.


The risk or severity of adverse effects can be increased when flurazepam is combined with DESFLURANE.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with chlorothiazide.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with fludiazepam.


The risk or severity of adverse effects can be increased when pirenzepine is combined with Butylscopolamine.


The risk or severity of adverse effects can be increased when Enalaprilat is combined with oxaprozin.


The risk or severity of adverse effects can be increased when pramipexole is combined with penbutolol.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with Alvimopan.


The risk or severity of adverse effects can be increased when Eplerenone is combined with nifedipine.


The risk or severity of adverse effects can be increased when zaleplon is combined with levodopa.


The risk or severity of adverse effects can be increased when Treprostinil is combined with Choline magnesium trisalicylate.


The risk or severity of adverse effects can be increased when RIMEXOLONE is combined with memantine.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when Vilazodone is combined with nortriptyline.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with phenobarbital.


The risk or severity of adverse effects can be increased when antipyrine is combined with CLOBETASOL PROPIONATE.


The risk or severity of adverse effects can be increased when rizatriptan is combined with FLUPHENAZINE.


The risk or severity of adverse effects can be increased when zolmitriptan is combined with Tapentadol.


The risk or severity of adverse effects can be increased when Enalaprilat is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when Ecabet is combined with meperidine.


The risk or severity of adverse effects can be increased when acemetacin is combined with triamcinolone.


The risk or severity of adverse effects can be increased when Tramadol is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when zaleplon is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when Etoricoxib is combined with formestane.


The risk or severity of adverse effects can be increased when Pipamperone is combined with Riociguat.


The risk or severity of adverse effects can be increased when salicylamide is combined with flurandrenolide.


The risk or severity of adverse effects can be increased when estazolam is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when Tavaborole is combined with VERAPAMIL.


The risk or severity of adverse effects can be increased when LEVOBUNOLOL is combined with Varenicline.


The risk or severity of adverse effects can be increased when mycophenolate mofetil is combined with resveratrol.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with periciazine.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with oxazepam.


The risk or severity of adverse effects can be increased when etizolam is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when propofol is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when Melatonin is combined with MELPERONE.


The risk or severity of adverse effects can be increased when thiopental is combined with Pipamperone.


The risk or severity of adverse effects can be increased when venlafaxine is combined with Perospirone.


The risk or severity of adverse effects can be increased when dipyridamole is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when brimonidine is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when amobarbital is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when methyclothiazide is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when nicergoline is combined with metyrapone.


The risk or severity of adverse effects can be increased when PERINDOPRIL is combined with carprofen.


The risk or severity of adverse effects can be increased when tolnaftate is combined with flunarizine.


The risk or severity of adverse effects can be increased when nicergoline is combined with glyburide.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with Candesartan cilexetil.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with tolazoline.


The risk or severity of adverse effects can be increased when meprobamate is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when Mometasone is combined with decamethonium.


The risk or severity of adverse effects can be increased when flurbiprofen is combined with tiaprofenic acid.


The risk or severity of adverse effects can be increased when diazepam is combined with Perospirone.


The risk or severity of adverse effects can be increased when SERATRODAST is combined with Risedronic acid.


The risk or severity of adverse effects can be increased when Pipamperone is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when atenolol is combined with minoxidil.


The risk or severity of adverse effects can be increased when methscopolamine is combined with Normethadone.


The risk or severity of adverse effects can be increased when epoprostenol is combined with mesalamine.


The risk or severity of adverse effects can be increased when tolmetin is combined with FLUOCINOLONE ACETONIDE.


The risk or severity of adverse effects can be increased when tolmetin is combined with Halobetasol.


The risk or severity of adverse effects can be increased when Sertaconazole is combined with nilvadipine.


The risk or severity of adverse effects can be increased when oxprenolol is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with butalbital.


The risk or severity of adverse effects can be increased when mesoridazine is combined with Normethadone.


The risk or severity of adverse effects can be increased when cabergoline is combined with Remoxipride.


The risk or severity of adverse effects can be increased when haloperidol is combined with dyclonine.


The risk or severity of adverse effects can be increased when meprobamate is combined with baclofen.


The risk or severity of adverse effects can be increased when metoclopramide is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when isradipine is combined with Riociguat.


The risk or severity of adverse effects can be increased when metoclopramide is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when meprobamate is combined with ethchlorvynol.


The risk or severity of adverse effects can be increased when DIMENHYDRINATE is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when benzyl alcohol is combined with tiapride.


The risk or severity of adverse effects can be increased when Etomidate is combined with Pramocaine.


The risk or severity of adverse effects can be increased when baclofen is combined with carisoprodol.


The risk or severity of adverse effects can be increased when Etomidate is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when halothane is combined with zotepine.


The risk or severity of adverse effects can be increased when mesalamine is combined with CLOCORTOLONE.


The risk or severity of adverse effects can be increased when Propoxycaine is combined with fexofenadine.


The risk or severity of adverse effects can be increased when ethopropazine is combined with biperiden.


The risk or severity of adverse effects can be increased when procaine is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when pergolide is combined with ethanol.


The risk or severity of adverse effects can be increased when epirizole is combined with budesonide.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with lithium ion.


The risk or severity of adverse effects can be increased when codeine is combined with Hexobarbital.


The risk or severity of adverse effects can be increased when codeine is combined with lithium ion.


The risk or severity of adverse effects can be increased when etodolac is combined with FLUOCORTOLONE.


The risk or severity of adverse effects can be increased when etodolac is combined with Fluprednidene.


The risk or severity of adverse effects can be increased when codeine is combined with Butethal.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with Phenelzine.


The risk or severity of adverse effects can be increased when nifedipine is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when sulpiride is combined with dyclonine.


The risk or severity of adverse effects can be increased when Vorapaxar is combined with phenindione.


The risk or severity of adverse effects can be increased when sulpiride is combined with propoxyphene.


The risk or severity of adverse effects can be increased when fluvoxamine is combined with desipramine.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with alclofenac.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with clidinium.


The risk or severity of adverse effects can be increased when estazolam is combined with mesoridazine.


The risk or severity of adverse effects can be increased when meprobamate is combined with prazepam.


The risk or severity of adverse effects can be increased when meprobamate is combined with quazepam.


The risk or severity of adverse effects can be increased when meprobamate is combined with oxprenolol.


The risk or severity of adverse effects can be increased when scopolamine is combined with tolterodine.


The risk or severity of adverse effects can be increased when meprobamate is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when MOXONIDINE is combined with nitroglycerin.


The risk or severity of adverse effects can be increased when chlormezanone is combined with butalbital.


The risk or severity of adverse effects can be increased when Tiotropium is combined with oxymorphone.


The risk or severity of adverse effects can be increased when propoxyphene is combined with fexofenadine.


The risk or severity of adverse effects can be increased when midazolam is combined with dyclonine.


The risk or severity of adverse effects can be increased when midazolam is combined with propoxyphene.


The risk or severity of adverse effects can be increased when scopolamine is combined with Metixene.


The risk or severity of adverse effects can be increased when Butoconazole is combined with diltiazem.


The risk or severity of adverse effects can be increased when ethosuximide is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when nisoldipine is combined with apraclonidine.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with droperidol.


The risk or severity of adverse effects can be increased when Ziprasidone is combined with levorphanol.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with loratadine.


The risk or severity of adverse effects can be increased when pyridostigmine is combined with pilocarpine.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with papaverine.


The risk or severity of adverse effects can be increased when tubocurarine is combined with Metixene.


The risk or severity of adverse effects can be increased when isradipine is combined with enalapril.


The risk or severity of adverse effects can be increased when CICLOPIROX is combined with Lercanidipine.


The risk or severity of adverse effects can be increased when Clofarabine is combined with clonidine.


The risk or severity of adverse effects can be increased when nicergoline is combined with Lomitapide.


The risk or severity of adverse effects can be increased when thiamylal is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when Clofarabine is combined with propranolol.


The risk or severity of adverse effects can be increased when nicergoline is combined with Ivacaftor.


The risk or severity of adverse effects can be increased when amitriptyline is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when thiamylal is combined with oxprenolol.


The risk or severity of adverse effects can be increased when Etidocaine is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when ketamine is combined with Paliperidone.


The risk or severity of adverse effects can be increased when Sacubitril is combined with tranylcypromine.


The risk or severity of adverse effects can be increased when Sacubitril is combined with tretinoin.


The risk or severity of adverse effects can be increased when paramethasone is combined with donepezil.


The risk or severity of adverse effects can be increased when thiothixene is combined with mepivacaine.


The risk or severity of adverse effects can be increased when diflunisal is combined with Lumiracoxib.


The risk or severity of adverse effects can be increased when methyclothiazide is combined with carbamazepine.


The risk or severity of adverse effects can be increased when Aceclofenac is combined with Risedronic acid.


The risk or severity of adverse effects can be increased when thiothixene is combined with Desloratadine.


The risk or severity of adverse effects can be increased when epoprostenol is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when nicotinic acid is combined with simvastatin.


The risk or severity of adverse effects can be increased when chlorthalidone is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when alprazolam is combined with Etidocaine.


The risk or severity of adverse effects can be increased when Fospropofol is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when docetaxel is combined with ofloxacin.


The risk or severity of adverse effects can be increased when thiamylal is combined with prazepam.


The risk or severity of adverse effects can be increased when docetaxel is combined with procarbazine.


The risk or severity of adverse effects can be increased when docetaxel is combined with arsenic trioxide.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with imipramine.


The risk or severity of adverse effects can be increased when tolmetin is combined with nimesulide.


The risk or severity of adverse effects can be increased when reserpine is combined with DESFLURANE.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with Lurasidone.


The risk or severity of adverse effects can be increased when rizatriptan is combined with clozapine.


The risk or severity of adverse effects can be increased when mirtazapine is combined with citalopram.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when reserpine is combined with isradipine.


The risk or severity of adverse effects can be increased when reserpine is combined with topiramate.


The risk or severity of adverse effects can be increased when reserpine is combined with Olmesartan.


The risk or severity of adverse effects can be increased when METAXALONE is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when chlorzoxazone is combined with clonidine.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with selegiline.


The risk or severity of adverse effects can be increased when PIPECURONIUM is combined with REMIFENTANIL.


The risk or severity of adverse effects can be increased when Ziprasidone is combined with topiramate.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with Bambuterol.


The risk or severity of adverse effects can be increased when perphenazine is combined with Asenapine.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with daunorubicin.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with clenbuterol.


The risk or severity of adverse effects can be increased when Pirlindole is combined with apraclonidine.


The risk or severity of adverse effects can be increased when Amrinone is combined with Pitavastatin.


The risk or severity of adverse effects can be increased when promazine is combined with butorphanol.


The risk or severity of adverse effects can be increased when nisoldipine is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when methocarbamol is combined with Olopatadine.


The risk or severity of adverse effects can be increased when duloxetine is combined with thiothixene.


The risk or severity of adverse effects can be increased when duloxetine is combined with Thioproperazine.


The risk or severity of adverse effects can be increased when sulpiride is combined with promethazine.


The risk or severity of adverse effects can be increased when Halazepam is combined with Retigabine.


The risk or severity of adverse effects can be increased when dextromethorphan is combined with maprotiline.


The risk or severity of adverse effects can be increased when oxazepam is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when benzyl alcohol is combined with maprotiline.


The risk or severity of adverse effects can be increased when PIRFENIDONE is combined with Halobetasol.


The risk or severity of adverse effects can be increased when Tapentadol is combined with selegiline.


The risk or severity of adverse effects can be increased when alprazolam is combined with quazepam.


The risk or severity of adverse effects can be increased when Tiotropium is combined with codeine.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with VALPROIC ACID.


The risk or severity of adverse effects can be increased when Pregabalin is combined with sertraline.


The risk or severity of adverse effects can be increased when ibuprofen is combined with halcinonide.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when midazolam is combined with zopiclone.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when alprazolam is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when ibuprofen is combined with difluprednate.


The risk or severity of adverse effects can be increased when Propoxycaine is combined with levodopa.


The risk or severity of adverse effects can be increased when nortriptyline is combined with desipramine.


The risk or severity of adverse effects can be increased when pergolide is combined with bifonazole.


The risk or severity of adverse effects can be increased when enalapril is combined with apraclonidine.


The risk or severity of adverse effects can be increased when ETOFENAMATE is combined with Tixocortol.


The risk or severity of adverse effects can be increased when enalapril is combined with methyldopa.


The risk or severity of adverse effects can be increased when lidocaine is combined with Retigabine.


The risk or severity of adverse effects can be increased when Arotinolol is combined with nisoldipine.


The risk or severity of adverse effects can be increased when Lumiracoxib is combined with Etoricoxib.


The risk or severity of adverse effects can be increased when Etoricoxib is combined with FLUOCINOLONE ACETONIDE.


The risk or severity of adverse effects can be increased when Carbetocin is combined with PERINDOPRIL.


The risk or severity of adverse effects can be increased when rasagiline is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when mycophenolic acid is combined with flunisolide.


The risk or severity of adverse effects can be increased when tenoxicam is combined with estrone.


The risk or severity of adverse effects can be increased when Carbetocin is combined with Candesartan cilexetil.


The risk or severity of adverse effects can be increased when Carbetocin is combined with tolazoline.


The risk or severity of adverse effects can be increased when celecoxib is combined with loteprednol.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with propofol.


The risk or severity of adverse effects can be increased when chloral hydrate is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when Linagliptin is combined with Temsirolimus.


The risk or severity of adverse effects can be increased when pirenzepine is combined with TRIMETHAPHAN.


The risk or severity of adverse effects can be increased when enalapril is combined with dipyridamole.


The risk or severity of adverse effects can be increased when ethopropazine is combined with Propiverine.


The risk or severity of adverse effects can be increased when Mephobarbital is combined with clidinium.


The risk or severity of adverse effects can be increased when nabumetone is combined with oxyphenbutazone.


The risk or severity of adverse effects can be increased when butorphanol is combined with Mersalyl.


The risk or severity of adverse effects can be increased when flunitrazepam is combined with Pipamperone.


The risk or severity of adverse effects can be increased when oxyphenonium is combined with meperidine.


The risk or severity of adverse effects can be increased when fluvoxamine is combined with procaine.


The risk or severity of adverse effects can be increased when clonidine is combined with zonisamide.


The risk or severity of adverse effects can be increased when Etidocaine is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when Articaine is combined with carisoprodol.


The risk or severity of adverse effects can be increased when Levoleucovorin is combined with tegafur.


The risk or severity of adverse effects can be increased when calcium lactate is combined with dihydrotachysterol.


The risk or severity of adverse effects can be increased when maprotiline is combined with promethazine.


The risk or severity of adverse effects can be increased when oxiconazole is combined with Pregabalin.


The risk or severity of adverse effects can be increased when losartan is combined with Bretylium.


The risk or severity of adverse effects can be increased when perphenazine is combined with triflupromazine.


The risk or severity of adverse effects can be increased when thioridazine is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when tioconazole is combined with nilvadipine.


The risk or severity of adverse effects can be increased when barnidipine is combined with tretinoin.


The risk or severity of adverse effects can be increased when ethanol is combined with ethionamide.


The risk or severity of adverse effects can be increased when barnidipine is combined with isoflurane.


The risk or severity of adverse effects can be increased when barnidipine is combined with tranylcypromine.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with meclizine.


The risk or severity of adverse effects can be increased when amphotericin b is combined with sotalol.


The risk or severity of adverse effects can be increased when Propoxycaine is combined with nortriptyline.


The risk or severity of adverse effects can be increased when Propoxycaine is combined with amoxapine.


The risk or severity of adverse effects can be increased when amphotericin b is combined with brimonidine.


The risk or severity of adverse effects can be increased when amphotericin b is combined with Nabilone.


The risk or severity of adverse effects can be increased when fluoxetine is combined with clomipramine.


The risk or severity of adverse effects can be increased when Pipamperone is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when perphenazine is combined with chlormezanone.


The risk or severity of adverse effects can be increased when midazolam is combined with quetiapine.


The risk or severity of adverse effects can be increased when perphenazine is combined with Escitalopram.


The risk or severity of adverse effects can be increased when midazolam is combined with ketamine.


The risk or severity of adverse effects can be increased when hydrochlorothiazide is combined with deslanoside.


The risk or severity of adverse effects can be increased when cefotetan is combined with ethanol.


The risk or severity of adverse effects can be increased when zotepine is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when Pramocaine is combined with Flibanserin.


The risk or severity of adverse effects can be increased when enflurane is combined with Flibanserin.


The risk or severity of adverse effects can be increased when Paliperidone is combined with ethchlorvynol.


The risk or severity of adverse effects can be increased when methylergonovine is combined with Lercanidipine.


The risk or severity of adverse effects can be increased when hydromorphone is combined with thiamylal.


The risk or severity of adverse effects can be increased when mefenamic acid is combined with epirizole.


The risk or severity of adverse effects can be increased when hydromorphone is combined with halothane.


The risk or severity of adverse effects can be increased when methylergonovine is combined with Caspofungin.


The risk or severity of adverse effects can be increased when atenolol is combined with floctafenine.


The risk or severity of adverse effects can be increased when docetaxel is combined with gemcitabine.


The risk or severity of adverse effects can be increased when propoxyphene is combined with baclofen.


The risk or severity of adverse effects can be increased when ILOPROST is combined with LEVOSIMENDAN.


The risk or severity of adverse effects can be increased when dichlorphenamide is combined with metformin.


The risk or severity of adverse effects can be increased when oxaprozin is combined with haloperidol.


The risk or severity of adverse effects can be increased when clidinium is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when Fospropofol is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when minoxidil is combined with nimodipine.


The risk or severity of adverse effects can be increased when Fospropofol is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when Fospropofol is combined with flunarizine.


The risk or severity of adverse effects can be increased when lorazepam is combined with ondansetron.


The risk or severity of adverse effects can be increased when lorazepam is combined with cocaine.


The risk or severity of adverse effects can be increased when lorazepam is combined with tiagabine.


The risk or severity of adverse effects can be increased when methadone is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when budesonide is combined with ROSOXACIN.